酸通过调节乳酸代谢和促进线粒体功能来改善骨肌肉的代谢不灵活性
Yu Wang1, Feijie Wang2, Juan Sun1
1State Key Laboratory of Food Science and Technology, School of Food Science and Technology, Jiangnan University, Wuxi, China.
Molecular nutrition & food research
|June 10, 2025
概括
酸在食高脂肪饮食的小鼠中改善了骨肌肉功能. 它通过调节乳酸代谢和促进线粒体脂肪酸氧化来增强代谢灵活性.
科学领域:
- 代谢研究的研究.
- 线粒体生物学 线粒体生物学
- 营养科学 营养科学
背景情况:
- 肥胖导致线粒体功能障碍,损害骨肌肉的代谢灵活性.
- 已知酸可调节新陈代谢平衡.
- 高脂肪饮食 (HFD) 诱导骨肌肉中的代谢障碍.
研究的目的:
- 研究酸对HFD诱导的骨肌肉代谢障碍的影响.
- 评估糖脂代谢,运动表现,肌肉纤维类型和抗氧化能力的变化.
- 用非目标代谢学来阐明潜在的代谢机制.
主要方法:
- 小鼠被分为三组,并接受HFD与或没有胆酸干预12周.
- 骨肌的评估包括代谢状态,运动能力,纤维类型和抗氧化能力.
- 使用非向代谢学和基于细胞的测试 (C2C12细胞) 来分析代谢途径.
主要成果:
- 酸降低了脂肪积累,改善了HFD养小鼠的运动表现和抗氧化能力.
- 代谢学揭示了酸对乳酸代谢和线粒体脂肪酸氧化的积极调节.
- 酸增加了脂肪酸氧化,抑制了乳酸生产,并减少了线粒体蛋白质的乳酸化.
结论:
- 酸可以改善高脂肪饮食引起的骨肌肉代谢障碍.
- 酸通过LDHA-乳酸轴增强线粒体功能和代谢灵活性.
- 这项研究强调了酸作为饮食引起的代谢疾病的潜在治疗剂.
更多相关视频
06:53Isolation and Differentiation of Primary Myoblasts from Mouse Skeletal Muscle Explants
Published on: October 15, 2019
17.6K
09:40Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
Published on: January 19, 2017
11.8K
相关概念视频
Muscle Recovery and Fatigue
2.6K
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...
2.6K
Skeletal Muscle Relaxants: Therapeutic Uses
632
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
632
Cross-bridge Cycle
118.4K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.4K
Skeletal Muscle Relaxants: Adverse Effects
485
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
485
Classification of Skeletal Muscle Relaxants
2.7K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.7K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
